MAX-40279 hemifumarateProduct ingredient for MAX-40279

Show full entry for MAX-40279
Name
MAX-40279 hemifumarate
Drug Entry
MAX-40279

MAX-40279 is under investigation in clinical trial NCT03412292 (MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)).

See full entry for MAX-40279
Accession Number
DBSALT003290
Structure
Synonyms
7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-(1-(piperidin-4-yl)-1H-pyrazol-4-yl) thieno [3,2-d]pyrimidin-2-amine semi-fumarate
UNII
JU19P2M2KM
CAS Number
Not Available
Not Available
Predicted Properties
Not Available